Background: Hepatic arterial infusion chemotherapy (HAIC) is one option for treating massive tumors and unresectable hepatocellular carcinoma (HCC). However, there is a lack of remedial treatment after these treatments are ineffective or failed. Summary: Some studies have discovered that HAIC has greater survival in patients with advanced HCC. A previous study has shown that HAIC is effective in the treatment of advanced HCC, and the data on randomized clinical trials are limited and unclear. Key Message: More clinical trials and research are needed in order to make HAIC a standard and recommended therapy for advanced HCC. Our review focuses on the clinical applications of hepatic artery infusion treatment.
Gastrointest Tumors

中文翻译：

---

肝动脉灌注化疗是肝细胞癌可行的治疗选择：新的更新

背景：肝动脉灌注化疗（HAIC）是治疗大块肿瘤和不可切除的肝细胞癌（HCC）的一种选择。然而，在这些治疗无效或失败后，缺乏补救治疗。总结：一些研究发现，HAIC 在晚期 HCC 患者中的存活率更高。先前的一项研究表明，HAIC 对晚期 HCC 的治疗有效，但随机临床试验的数据有限且不清楚。关键信息：需要更多的临床试验和研究，以使 HAIC 成为晚期 HCC 的标准和推荐疗法。我们的综述侧重于肝动脉灌注治疗的临床应用。
胃肠肿瘤